Index by author

January 01, 2020; Volume 87,Issue 1

  1. Bangalore, Sripal

    1. Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
      Robert Fakheri, MD, Sripal Bangalore, MD and Franz Messerli, MD
      Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9; DOI: https://doi.org/10.3949/ccjm.87c.01001

  2. Bhandari, Sunil

    1. In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
      Sunil Bhandari, MBChB, FRCP, PhD, M Clin Edu, FHEA, Tasnim Momoniat, MBChB, MRCP (UK) and Duha Ilyas, MBBS, MRCP (UK)
      Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.87c.01002
Back to top

In this issue